Nepenthea Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$5M
Nepenthea General Information
Description
Developer of marijuana and related products created for medical applications. The company specializes in the cultivation, delivery and dispensing of medical marijuana, enabling the medical community and patients to combat and ease specific medical conditions.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Cultivation
Drug Discovery
Pharmaceuticals
Primary Office
- 33 Quail Road
- Rocky Point, NY 11778
- United States
+1 (516) 000-0000
Nepenthea Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 07-Jul-2015 | $5M | 000 | Completed | Startup |
Nepenthea Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Charles Todaro | Chief Executive Officer and Managing Member | ||
| Christopher Etts | Chief Operating Officer | ||
| Dean Pappas | Chief Medical Officer |